As reported in PBR yesterday, Dr. Reddy's is opening a new manufacturing facility in Mexico to supply pharma grade mPEG alcohols. This new cGMP facility will be part of the Custom Pharmaceutical Services (CPS) business within Dr. Reddy's.
mPEG alcohols are the key ingredient in activated mPEG alcohols used extensively in the pegylation of biological drugs - and are becoming more commonly used with peptides and small molecules too. The new plant will be able to produce a range of mPEG alcohol MWs and will have multi-ton capacity. PEGtech will be the brand name of these products.
The mPEG alcohol raw materials will feed the Reddy Mirfield, UK plant where the activation steps are carried out. This represents further backward integration of the Reddy operations able to support commercial scale in what Reddy's perceive is a key growth area in drug delivery.
Further, this is in keeping with Dr. Reddy's stated goal of one day being a leader in biosimilars as this capability can be used to augment that offering as it develops.
Posted by Bruce Lehr March 20th 2010